HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kenji Kadomatsu Selected Research

3,3'-iminodipropionitrile

8/2017Differential activation of neuronal and glial STAT3 in the spinal cord of the SOD1G93A mouse model of amyotrophic lateral sclerosis.
1/2016Comparative morphometric analysis of microglia in the spinal cord of SOD1(G93A) transgenic mouse model of amyotrophic lateral sclerosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kenji Kadomatsu Research Topics

Disease

39Neoplasms (Cancer)
12/2021 - 06/2002
16Inflammation (Inflammations)
01/2018 - 11/2004
13Neuroblastoma
08/2021 - 10/2008
9Spinal Cord Injuries (Spinal Cord Injury)
01/2021 - 04/2010
8Wounds and Injuries (Trauma)
05/2021 - 05/2003
7Fibrosis (Cirrhosis)
08/2018 - 05/2003
6Ischemia
07/2015 - 04/2005
6Carcinoma (Carcinomatosis)
10/2008 - 06/2002
5Kidney Diseases (Kidney Disease)
01/2019 - 06/2011
5Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
08/2017 - 11/2015
5Carcinogenesis
01/2015 - 06/2005
4Multiple Sclerosis
01/2021 - 03/2012
4Hyperplasia
01/2021 - 09/2006
4Acute Kidney Injury (Acute Renal Failure)
08/2018 - 10/2014
4Diabetic Nephropathies (Diabetic Nephropathy)
01/2018 - 01/2006
4Hypertension (High Blood Pressure)
08/2015 - 06/2009
4Prostatic Neoplasms (Prostate Cancer)
04/2015 - 05/2004
4Reperfusion Injury
02/2014 - 01/2002
3Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
01/2021 - 05/2014
3Neurodegenerative Diseases (Neurodegenerative Disease)
01/2017 - 01/2013
3Arthritis (Polyarthritis)
01/2017 - 10/2010
3Chronic Renal Insufficiency
05/2016 - 04/2010
3Neointima
02/2014 - 05/2005
3Brain Injuries (Brain Injury)
03/2009 - 08/2006
2Psoriasis (Pustulosis Palmaris et Plantaris)
12/2021 - 01/2021
2Dermatitis
12/2021 - 12/2013
2Stomach Neoplasms (Stomach Cancer)
07/2020 - 10/2007
2Hypoxia (Hypoxemia)
01/2020 - 01/2018
2Proteinuria
01/2019 - 08/2015
2Atherosclerosis
12/2017 - 06/2008
2Neuroinflammatory Diseases
08/2017 - 01/2016
2Lupus Nephritis
04/2017 - 05/2015
2Alzheimer Disease (Alzheimer's Disease)
01/2017 - 02/2004
2Heart Failure
05/2016 - 01/2016
2Renal Insufficiency (Renal Failure)
05/2016 - 04/2005
2Colorectal Neoplasms (Colorectal Cancer)
10/2015 - 03/2011
2Pathologic Constriction (Stenosis)
02/2014 - 06/2008
2Glomerulonephritis
02/2013 - 06/2011
2Contact Dermatitis (Eczema, Contact)
02/2012 - 02/2008
2Infarction (Infarctions)
01/2011 - 10/2006
2Myocardial Infarction
04/2010 - 02/2009
2Gliosis
11/2006 - 08/2006

Drug/Important Bio-Agent (IBA)

50MidkineIBA
08/2021 - 01/2002
27Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
08/2021 - 06/2002
17Proteins (Proteins, Gene)FDA Link
12/2021 - 05/2005
14Heparin (Liquaemin)FDA LinkGeneric
08/2021 - 06/2002
13Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))IBA
12/2021 - 05/2003
11Keratan SulfateIBA
01/2017 - 08/2006
10Small Interfering RNA (siRNA)IBA
04/2015 - 05/2004
8Biological ProductsIBA
03/2021 - 11/2004
6EnzymesIBA
01/2021 - 03/2003
6atelocollagenIBA
04/2015 - 06/2002
5Chondroitin Sulfates (Chondroitin Sulfate)IBA
01/2021 - 03/2009
5LipopolysaccharidesIBA
08/2017 - 04/2002
5Matrix Metalloproteinases (MMPs)IBA
04/2016 - 05/2003
4Therapeutic UsesIBA
09/2017 - 02/2012
4AcetylglucosamineIBA
12/2015 - 08/2006
4Hyaluronic Acid (Hyaluronan)IBA
07/2015 - 01/2011
3LigandsIBA
12/2021 - 07/2009
3ErbB Receptors (EGF Receptor)IBA
02/2021 - 05/2016
3NF-kappa B (NF-kB)IBA
01/2019 - 11/2006
3Polysaccharides (Glycans)IBA
01/2017 - 01/2014
3Messenger RNA (mRNA)IBA
01/2016 - 11/2006
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2015 - 05/2004
3Cisplatin (Platino)FDA LinkGeneric
12/2009 - 11/2004
3Antisense OligonucleotidesIBA
06/2008 - 02/2004
2Imiquimod (Aldara)FDA LinkGeneric
12/2021 - 01/2021
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2021 - 11/2006
2FructoseIBA
01/2019 - 01/2018
2Interleukin-18 (Interleukin 18)IBA
01/2019 - 08/2017
2Metalloproteases (Metalloproteinases)IBA
01/2019 - 07/2015
2Chondroitin Sulfate ProteoglycansIBA
12/2017 - 08/2013
2CollagenIBA
08/2017 - 04/2015
2Bleomycin (Blenoxane)FDA LinkGeneric
08/2017 - 05/2003
2Transforming Growth Factors (Transforming Growth Factor)IBA
08/2017 - 07/2015
2Biomarkers (Surrogate Marker)IBA
08/2017 - 06/2008
23,3'-iminodipropionitrileIBA
08/2017 - 01/2016
2E-SelectinIBA
07/2015 - 07/2009
2Chondroitin ABC LyaseIBA
04/2015 - 03/2012
2Nucleotide AptamersIBA
02/2013 - 03/2012
2Tumor Biomarkers (Tumor Markers)IBA
07/2012 - 03/2003
2Proteoglycans (Proteoglycan)IBA
03/2012 - 11/2011
2Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
02/2012 - 02/2008
2Combined Antibody TherapeuticsIBA
06/2011 - 10/2010
2Collagen Type II (Type II Collagen)IBA
06/2011 - 10/2010
2DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA
01/2011 - 12/2009
2AntibodiesIBA
04/2010 - 07/2007
2Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
04/2010 - 06/2009
2Low Density Lipoprotein Receptor-Related Protein-1 (LDL-Receptor Related Protein)IBA
11/2007 - 02/2004
2Streptozocin (Streptozotocin)FDA Link
09/2007 - 01/2006
2Catalytic RNA (Ribozymes)IBA
06/2005 - 02/2004
2Thymidine KinaseIBA
01/2004 - 01/2002
2ProdrugsIBA
01/2004 - 01/2002
2Ganciclovir (Cytovene)FDA LinkGeneric
01/2004 - 01/2002

Therapy/Procedure

19Therapeutics
01/2019 - 06/2002
3Nephrectomy
05/2016 - 06/2009
3Intravenous Administration
04/2015 - 10/2010
3Intraperitoneal Injections
06/2011 - 10/2010
2Drug Therapy (Chemotherapy)
02/2021 - 09/2017
2Intravenous Injections
01/2019 - 12/2009